| HOME >> MEDICINE >> TECHNOLOGY |
Brunswick Group
Josh Gartner
E-mail:shangpharma@brunswickgroup.com
Phone: 86-10-5960-8600SHANGPHARMA CORPORATION
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEET
(in thousands of U.S. dollars, except for ordinary share data) December 31,
June 30, 2011
2012ASSETSCurrent assets: Cash and cash equivalents
37,778
34,738 Restricted cash
2,562
1,156 Accounts receivable, net
23,974
27,203 Amounts due from related parties
503
765 Inventories
2,842
2,752 Prepayments and others
4,425
2,683 Deferred tax assets
264
925Total current assets72,34870,222Non-current assets: Derivative assets
7
- Property, plant, equipment and software, net
86,521
88,583 Land use right, net
6,634
6,539 Other long-term assets
559
633 Amounts due from related parties
225
224 Deferred tax assets
609
620Total non-current assets94,55596,599Total assets166,903166,821LIABILITIESCurrent liabilities: Accounts payable
16,307
15,331 Amounts due to related parties
123
489 Salary and welfare payable
3,864
2,325 Income tax payable
3,241
1,437 Advance from customers
1,596
738 Other payables and accruals
5,613
4,998Total current liabilities30,74425,318Non-current liabilities: Advanced subsidies3,121
4,179Total non-current liabilities3,1214,179Total liabilities33,86529,497Commitments and contingenciesEQUITYOrdinary s
'/>"/>
| SOURCE ShangPharma Corporation Copyright©2012 PR Newswire. All rights reserved |